论文信息 - Reply to Badri et al. on 'Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis'. - 字舞流文

Reply to Badri et al. on 'Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis'.

J. Ioannidis | T. Trikalinos | E. Panidou

[1] J. Ioannidis,et al. Limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis , 2004, AIDS.

[2] K. Hertogs,et al. Long-term efficacy of routine access to antiretroviral-resistance testing in HIV type 1-infected patients: results of the clinical efficacy of resistance testing trial. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3] Pierre-Marie Girard,et al. Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial , 2002, AIDS.

[4] A. Antinori,et al. Usefulness of monitoring HIV drug resistance and adherence in individuals failing highly active antiretroviral therapy: a randomized study (ARGENTA) , 2002, AIDS.

[5] Lidia Ruiz,et al. Clinical utility of HIV-1 genotyping and expert advice: the Havana trial , 2002, AIDS.

[6] J. Ioannidis,et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. , 2001, JAMA.

[7] T. Merigan,et al. A randomized study of antiretroviral management based on plasma genotypic antiretroviral resistance testing in patients failing therapy , 2000 .